Teladoc Health (NYSE:TDOC) Updates Q1 2025 Earnings Guidance

Teladoc Health (NYSE:TDOC) updated its first quarter 2025 earnings guidance on Wednesday. The company provided EPS guidance of -0.400–0.150 for the period, compared to the consensus EPS estimate of -0.370. The company issued revenue guidance of $608.0 million-$629.0 million, compared to the consensus revenue estimate of $633.0 million. Teladoc Health also updated its FY 2025 guidance to -1.100–0.500 EPS.

Analyst Ratings Changes

TDOC has been the subject of a number of analyst reports. Royal Bank of Canada increased their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a report on Friday, January 24th. The Goldman Sachs Group boosted their target price on Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research report on Tuesday, February 18th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research note on Friday, November 1st. TD Cowen lowered their target price on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Finally, Bank of America increased their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Eleven analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $11.44.

Teladoc Health Stock Down 1.6 %

Shares of TDOC traded down $0.16 during midday trading on Friday, reaching $9.35. 3,664,550 shares of the stock were exchanged, compared to its average volume of 8,259,777. The company has a market capitalization of $1.61 billion, a P/E ratio of -1.62 and a beta of 1.04. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. Teladoc Health has a 52 week low of $6.76 and a 52 week high of $15.95. The company’s 50 day moving average is $10.62 and its two-hundred day moving average is $9.53.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. On average, sell-side analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current year.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. This trade represents a 45.25 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.95% of the stock is currently owned by corporate insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.